Page 27 - Read Online
P. 27

Nguyen et al. Cancer Drug Resist 2018;1:126-38                                    Cancer
               DOI: 10.20517/cdr.2018.08                                             Drug Resistance




               Review                                                                        Open Access


               Glutamine metabolism in cancer therapy

               Tra-Ly Nguyen, Raúl V. Durán

               Institut Européen de Chimie et Biologie, INSERM U1218, Université de Bordeaux, 2 Rue Robert Escarpit, 33607 Pessac,
               France.

               Correspondence to: Dr. Raúl V. Durán, Institut Européen de Chimie et Biologie, INSERM U1218, Université de Bordeaux, 2 Rue
               Robert Escarpit, 33607 Pessac, France. E-mail: raul.duran@inserm.fr

               How to cite this article: Nguyen TL, Durán RV. Glutamine metabolism in cancer therapy. Cancer Drug Resist  2018;1:126-38.
                http://dx.doi.org/10.20517/cdr.2018.08

               Received: 28 Jun 2018    First Decision: 23 Jul 2018    Revised: 21 Aug 2018    Accepted: 3 Sep 2018    Published: 19 Sep 2018
               Science Editors: Elisa Giovannetti, Jose Antonio Rodriguez    Copy Editor: Yuan-Li Wang    Production Editor: Huan-Liang Wu



               Abstract
               The amino acid glutamine plays a key role in the metabolism of highly proliferating cells. During malignant
               transformation, cancer cells modify the consumption and processing of glutamine to sustain cell growth and proliferation.
               In some cases, these cancer cells become addicted to glutamine. Thus, targeting the metabolism of glutamine has been
               developed during last years as a potential strategy against cancer. In this review, we summarized the last advances in our
               knowledge about the role of glutamine metabolism in cancer therapy.

               Keywords: Cancer, glutamine, glutamoptosis, metabolism, mammalian target of rapamycin




               INTRODUCTION
               Since the discovery of the “Warburg effect” about the reprogramming of glucose metabolism in the 1920s,
               there is a massive interest in understanding cancer metabolism for therapeutic benefits. Glucose and gluta-
               mine are two most important nutrients used by cancer cells for their proliferation and growth. While the
               glycolytic pathway produces ATP and metabolic intermediates for biosynthesis, glutamine metabolism can
               supply amino acids, nucleic acids and glutathione necessary for cell proliferation. In this review, we de-
               scribe the metabolic transformation in cancer cells, then summarize different roles of glutamine in cancer
               metabolism in biosynthesis and stress protection. Finally, we discuss potential cancer therapy targeting ap-
               proaches based on glutamine metabolism.


               METABOLIC TRANSFORMATION IN CANCER CELLS
                                                  [1]
               Among the different hallmarks of cancer , metabolic transformation plays a key role in the adaptation of
                           © The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                    www.cdrjournal.com
   22   23   24   25   26   27   28   29   30   31   32